PMC:7247521 / 17763-18178
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T174 | 258-267 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T175 | 284-293 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T103 | 251-257 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T104 | 281-282 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T105 | 295-296 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
| T106 | 397-399 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T99 | 209-280 | Sentence | denotes | Fig. 1 Venn diagram of the five formulae’ active compounds and targets. |
| T100 | 281-306 | Sentence | denotes | A: compounds, B: targets. |
| T101 | 308-371 | Sentence | denotes | 3.2 Functional and pathway enrichment analyses of QFPD targets |